1. A phase 1b study of once‐weekly carfilzomib combined with lenalidomide and dexamethasone in patients with newly diagnosed multiple myeloma. Issue 2 (15th December 2020) Authors: Alsina, Melissa; Landgren, Ola; Raje, Noopur; Niesvizky, Ruben; Bensinger, William I.; Berdeja, Jesus G.; Kovacsovics, Tibor; Vesole, David H.; Fang, Belle; Kimball, Amy S.; Siegel, David S. Journal: American journal of hematology Issue: Volume 96:Issue 2(2021) Page Start: 226 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A phase II study of the efficacy, safety, and determinants of response to 5-azacitidine (Vidaza®) in patients with chronic myelomonocytic leukemia. Issue 10 (2nd October 2016) Authors: Tantravahi, Srinivas K.; Szankasi, Philippe; Khorashad, Jamshid S.; Dao, Kim-Hien; Kovacsovics, Tibor; Kelley, Todd W.; Deininger, Michael W. Journal: Leukemia & lymphoma Issue: Volume 57:Issue 10(2016:Oct.) Page Start: 2441 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Chronotropic incompetence and autonomic dysfunction as mechanisms of dyspnoea in patients with late stage cardiac amyloidosis. (29th March 2019) Authors: Nativi-Nicolau, Jose; Stehlik, Josef; Al-Dulaimi, Ragheed; Rodriguez, Carlos; Jaramillo, Javier; Conte, Jorge; Kovacsovics, Tibor; Cowley, Jared; Abraham, Jo; Barrel, Kelsey; Drakos, Stavros; Ryan, John; Maurer, Mathew S.; Fang, James Journal: Amyloid Issue: Volume 26(2019)Supplement 1 Page Start: 134 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Clinical and economic analysis of patients with acute myeloid leukemia by FLT3 status and midostaurin use at a Comprehensive Cancer Center. (December 2019) Authors: Willis, Connor; Menon, Jyothi; Unni, Sudhir; Au, Trang; Yoo, Minkyoung; Biskupiak, Joseph; Brixner, Diana; Ndife, Briana; Joseph, George; Bonifacio, Gaetano; Stein, Eytan; Tantravahi, Srinivas; Shami, Paul J.; Kovacsovics, Tibor; Stenehjem, David Journal: Leukemia research Issue: Volume 87(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Cost-effectiveness of technetium pyrophosphate scintigraphy versus heart biopsy for the diagnosis of transthyretin amyloidosis. (29th March 2019) Authors: Ruiz-Negrón, Natalia; Nativi-Nicolau, Jose; Maurer, Mathew S.; Moran, Andrew E.; Kovacsovics, Tibor; Bellows, Brandon K. Journal: Amyloid Issue: Volume 26(2019)Supplement 1 Page Start: 71 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. CPX-351 exhibits potent and direct ex vivo cytotoxicity against AML blasts with enhanced efficacy for cells harboring the FLT3-ITD mutation. (February 2017) Authors: Gordon, Max J.; Tardi, Paul; Loriaux, Marc M.; Spurgeon, Stephen E.; Traer, Elie; Kovacsovics, Tibor; Mayer, Lawrence D.; Tyner, Jeffrey W. Journal: Leukemia research Issue: Volume 53(2017:Feb.) Page Start: 39 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. GABA-A Receptor Encephalitis After Autologous Hematopoietic Stem Cell Transplant forMultiple Myeloma: Three Cases and Literature Review. Issue 6 (26th November 2022) Authors: Hoshina, Yoji; Galli, Jonathan; Wong, Ka-Ho; Kovacsovics, Tibor; Steinbach, Mary; Salzman, Karen L.; McNally, Joseph Scott; Lancaster, Eric; Paz Soldán, M. Mateo; Clardy, Stacey L. Journal: Neurology Issue: Volume 9:Issue 6(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. MTHFR C677T polymorphism is associated with methotrexate-induced myelopathy risk. (7th February 2017) Authors: Juster-Switlyk, Kelsey; Smith, A. Gordon; Kovacsovics, Tibor; Stephens, Deborah; Glenn, Martha; Palmer, Cheryl Ann; Quigley, Edward P.; Kolb, Noah Journal: Neurology Issue: Volume 88:Number 6(2017) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. MTHFR C677T polymorphism is associated with methotrexate-induced myelopathy risk. (7th February 2017) Authors: Juster-Switlyk, Kelsey; Smith, A. Gordon; Kovacsovics, Tibor; Stephens, Deborah; Glenn, Martha; Palmer, Cheryl Ann; Quigley, Edward P.; Kolb, Noah Journal: Neurology Issue: Volume 88:Number 6(2017) Page Start: 603 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Quizartinib, an FLT3 inhibitor, as monotherapy in patients with relapsed or refractory acute myeloid leukaemia: an open-label, multicentre, single-arm, phase 2 trial. Issue 7 (July 2018) Authors: Cortes, Jorge; Perl, Alexander E; Döhner, Hartmut; Kantarjian, Hagop; Martinelli, Giovanni; Kovacsovics, Tibor; Rousselot, Philippe; Steffen, Björn; Dombret, Hervé; Estey, Elihu; Strickland, Stephen; Altman, Jessica K; Baldus, Claudia D; Burnett, Alan; Krämer, Alwin; Russell, Nigel; Shah, Neil P;... Journal: Lancet oncology Issue: Volume 19:Issue 7(2018) Page Start: 889 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗